Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy

Eur J Heart Fail. 2021 Mar;23(3):486-488. doi: 10.1002/ejhf.2098. Epub 2021 Jan 25.

Authors

Daniela Tomasoni¹, Mark C Petrie², Marianna Adamo¹, Marco Metra¹

Affiliations

¹ Cardiology and Cardiac Catheterization Laboratory, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
² British Heart Foundation Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aldosterone
Angiotensin Receptor Antagonists
Angiotensins
COVID-19*
Heart Failure*
Hospitalization
Humans
Registries
Renin
Renin-Angiotensin System
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists
Angiotensins
Aldosterone
Renin